REGN5668
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN5668, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]